Cognoa转发了
CEO, Associate Professor, Pediatric Neurology & Clinical Informatics - Former Division Chief | Innovation, Medical Devices & AI in healthcare
The latest JAMA Network Health Systems & Recruitment study covered by Becker's Healthcare and highlights autism as the fastest-growing healthcare expense in the U.S., with a 13% annual growth rate! This underscores the urgent need for innovative solutions to address both the human and economic costs of autism. I’m proud that Cognoa's AI-powered diagnostic, Canvas Dx, is at the forefront of tackling this challenge. By enabling earlier and more accessible autism diagnosis, we’re not just improving outcomes for children and families – we’re also helping to reduce long-term healthcare costs. Key benefits of Canvas Dx: 1. Earlier intervention: Diagnoses possible from 18 months, when interventions are most effective 2. Improved access: Usable by primary care providers and increased efficiency by specialists, reducing wait times and travel burdens 3. Cost savings: Early diagnosis and intervention can significantly reduce long-term healthcare expenses Wyoming Medicaid's decision to cover Canvas Dx for example, is projected to save the state at least $2.8 million annually. This model of integrating AI-enhanced diagnostics could be replicated nationwide, potentially saving billions in Medicaid expenditures. As we confront the rising costs of autism care, it’s clear that innovative technologies like Canvas Dx are not just beneficial – they’re essential. By improving access to early diagnosis and intervention, we can create better outcomes for children while also addressing the economic challenges highlighted in the JAMA study. Let’s work together to ensure that all children have access to timely, accurate autism diagnosis and the support they need to thrive. #autism #AutismAwareness #HealthcareInnovation #AIinHealthcare #EarlyIntervention